Cryo-Cell International, Inc.
CCEL
Rank in Stocks
#23646
Cryo-Cell International, Inc. engages in cord blood and cord tissue... Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Share Price
$4.99
Last synced: 2026-11-09
Market Cap
$40.23M
Change (1 day)
2.04%
Change (1 year)
23.51%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Cryo-Cell International, Inc. (CCEL)
Category
Healthcare
Operating Margin for Cryo-Cell International, Inc. (CCEL)
Operating Margin as of November 2026 TTM: 0.61%
According to Cryo-Cell International, Inc.'s latest financial reports, its current operating margin (TTM) is 0.61%. At the end of 2025 the company had an operating margin of 15.34%.
Operating Margin history for Cryo-Cell International, Inc. from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.61% | -96.02% |
| 2025 | 15.34% | 40.99% |
| 2024 | 10.88% | -127.71% |
| 2023 | -39.26% | -395.86% |
| 2022 | 13.27% | -4.60% |
| 2021 | 13.91% | -43.46% |
| 2020 | 24.60% | 54.62% |
| 2019 | 15.91% | -10.42% |
| 2018 | 17.76% | -9.94% |
| 2017 | 19.72% | 954.55% |
| 2016 | 1.87% | -86.56% |
| 2015 | 13.91% | 41.36% |
| 2014 | 9.84% | 9.82% |
| 2013 | 8.96% | -194.12% |
| 2012 | -9.52% | 518.18% |
| 2011 | -1.54% | -108.43% |
| 2010 | 18.27% | 78.42% |
| 2009 | 10.24% | -641.80% |
| 2008 | -1.89% | -92.94% |
| 2007 | -26.76% | 55.31% |
| 2006 | -17.23% | -303.42% |
| 2005 | 8.47% | -67.47% |
| 2004 | 26.04% | -126.13% |
| 2003 | -99.64% | 27.29% |
| 2002 | -78.28% | 810.23% |
| 2001 | -8.60% | -91.61% |
| 2000 | -102.45% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.34% | -74.85% |
US
|
|
| 9.60% | -84.26% |
DE
|
|
| 19.85% | -67.46% |
US
|
|
| 18.76% | -69.25% |
SA
|
|
| 6.10% | -90.00% |
CN
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Cryo-Cell International, Inc.'s operating margin
What is Cryo-Cell International, Inc.'s operating margin?
Cryo-Cell International, Inc.'s operating margin is 0.61%, as of Nov 2026.
What was Cryo-Cell International, Inc.'s operating margin in 2025?
In 2025, Cryo-Cell International, Inc.'s operating margin was 15.34%, compared with 10.88% in 2024.
How has Cryo-Cell International, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Cryo-Cell International, Inc.'s operating margin was highest in 2020 (24.60%) and lowest in 2023 (-39.26%).
How does Cryo-Cell International, Inc.'s operating margin compare with similar companies?
Cryo-Cell International, Inc.'s operating margin (0.61%) is lower than that of all 5 similar companies listed above. The highest among them is Tenet Healthcare Corporation, with 19.85%.